Key Record Dates Identifier: NCT03631199
Brief Title: Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects (CANOPY-1)

First Submitted : August 6, 2018
First Submitted that Met QC Criteria : August 10, 2018
First Posted : August 15, 2018

Last Update Submitted that Met QC Criteria : September 10, 2021
Last Update Posted : September 13, 2021